PORTLAND In 2013, the Phil and Penny Knight Foundation issued a challenge to Oregon Health and Science University, to raise $500 million for the Knight Cancer Institute.
In turn, the foundation would match that amount, raising a total of $1 billion for charity. OHSU has raised $311 million so far, thanks in part to local companies.
On Wednesday, Dr. Brian Druker spoke to employees at Standard Insurance about joining the challenge.
Druker heads the Knight Cancer Institute and played a leading role in the development of breakthough cancer drug, Gleevac.
We took a leukemia that we once told people had a 3-5 year life expectancy, and turned it into a disease that we now expect people to live a normal lifespan by taking a pill, once a day, he said.
To donate to the challenge, click here.